21-46111481-T-C

Variant summary

Our verdict is Uncertain significance. The variant received 2 ACMG points: 2P and 0B. PM2

The NM_001849.4(COL6A2):​c.5T>C​(p.Leu2Pro) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant was absent in control chromosomes in GnomAD project. Variant has been reported in ClinVar as Uncertain significance (★).

Frequency

Genomes: not found (cov: 30)

Consequence

COL6A2
NM_001849.4 missense

Scores

1
10
8

Clinical Significance

Uncertain significance criteria provided, single submitter U:1

Conservation

PhyloP100: 0.165

Publications

0 publications found
Variant links:
Genes affected
COL6A2 (HGNC:2212): (collagen type VI alpha 2 chain) This gene encodes one of the three alpha chains of type VI collagen, a beaded filament collagen found in most connective tissues. The product of this gene contains several domains similar to von Willebrand Factor type A domains. These domains have been shown to bind extracellular matrix proteins, an interaction that explains the importance of this collagen in organizing matrix components. Mutations in this gene are associated with Bethlem myopathy and Ullrich scleroatonic muscular dystrophy. Three transcript variants have been identified for this gene. [provided by RefSeq, Jul 2008]
COL6A2 Gene-Disease associations (from GenCC):
  • collagen 6-related myopathy
    Inheritance: AD, AR Classification: DEFINITIVE Submitted by: ClinGen
  • Ullrich congenital muscular dystrophy 1B
    Inheritance: AR, AD Classification: DEFINITIVE Submitted by: G2P
  • Bethlem myopathy 1A
    Inheritance: AD, AR Classification: STRONG Submitted by: Genomics England PanelApp
  • Ullrich congenital muscular dystrophy 1A
    Inheritance: AD, AR Classification: STRONG Submitted by: Labcorp Genetics (formerly Invitae), Genomics England PanelApp
  • Bethlem myopathy
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
  • Ullrich congenital muscular dystrophy
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
  • myosclerosis
    Inheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Uncertain_significance. The variant received 2 ACMG points.

PM2
Very rare variant in population databases, with high coverage;

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
COL6A2NM_001849.4 linkc.5T>C p.Leu2Pro missense_variant Exon 2 of 28 ENST00000300527.9 NP_001840.3 P12110-1A0A384MDP3
COL6A2NM_058174.3 linkc.5T>C p.Leu2Pro missense_variant Exon 2 of 28 NP_478054.2 P12110-2
COL6A2NM_058175.3 linkc.5T>C p.Leu2Pro missense_variant Exon 2 of 28 NP_478055.2 P12110-3
LOC124905043XR_007067910.1 linkn.551A>G non_coding_transcript_exon_variant Exon 1 of 2

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
COL6A2ENST00000300527.9 linkc.5T>C p.Leu2Pro missense_variant Exon 2 of 28 1 NM_001849.4 ENSP00000300527.4 P12110-1
COL6A2ENST00000397763.6 linkc.5T>C p.Leu2Pro missense_variant Exon 2 of 28 5 ENSP00000380870.1 P12110-2
COL6A2ENST00000409416.6 linkc.5T>C p.Leu2Pro missense_variant Exon 1 of 27 5 ENSP00000387115.1 P12110-3
COL6A2ENST00000436769.5 linkc.5T>C p.Leu2Pro missense_variant Exon 2 of 3 2 ENSP00000390418.1 C9JH44

Frequencies

GnomAD3 genomes
Cov.:
30
GnomAD4 exome
Cov.:
31
GnomAD4 genome
Cov.:
30

ClinVar

Significance: Uncertain significance
Submissions summary: Uncertain:1
Revision: criteria provided, single submitter
LINK: link

Submissions by phenotype

Inborn genetic diseases Uncertain:1
Mar 12, 2024
Ambry Genetics
Significance:Uncertain significance
Review Status:criteria provided, single submitter
Collection Method:clinical testing

The c.5T>C (p.L2P) alteration is located in exon 2 (coding exon 1) of the COL6A2 gene. This alteration results from a T to C substitution at nucleotide position 5, causing the leucine (L) at amino acid position 2 to be replaced by a proline (P). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.096
BayesDel_addAF
Uncertain
0.12
D
BayesDel_noAF
Uncertain
-0.060
CADD
Benign
21
DANN
Uncertain
0.98
DEOGEN2
Benign
0.25
T;.;T;.;.
Eigen
Benign
-0.13
Eigen_PC
Benign
-0.22
FATHMM_MKL
Uncertain
0.84
D
LIST_S2
Benign
0.18
T;T;T;.;T
M_CAP
Pathogenic
0.48
D
MetaRNN
Uncertain
0.47
T;T;T;T;T
MetaSVM
Uncertain
-0.038
T
MutationAssessor
Benign
2.0
M;M;.;M;M
PhyloP100
0.17
PrimateAI
Uncertain
0.61
T
PROVEAN
Benign
-2.2
N;N;N;N;N
REVEL
Uncertain
0.45
Sift
Uncertain
0.0070
D;D;D;D;D
Sift4G
Uncertain
0.0070
D;D;D;D;D
Polyphen
0.91
P;D;.;D;D
Vest4
0.31
MutPred
0.35
Gain of catalytic residue at L2 (P = 0.0097);Gain of catalytic residue at L2 (P = 0.0097);Gain of catalytic residue at L2 (P = 0.0097);Gain of catalytic residue at L2 (P = 0.0097);Gain of catalytic residue at L2 (P = 0.0097);
MVP
0.98
MPC
0.71
ClinPred
0.44
T
GERP RS
3.0
PromoterAI
0.010
Neutral
Varity_R
0.40
gMVP
0.84
Mutation Taster
=72/28
polymorphism

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

hg19: chr21-47531395; API